Women with rheumatoid arthritis (RA) experience reduced fertility and face increased risks during pregnancy, including a moderately elevated miscarriage rate of up to 20% and significantly higher odds of preterm birth. However, most women with RA can have successful pregnancies when their disease is well controlled before conception, and close coordination between rheumatologists and maternal-fetal medicine specialists can substantially improve outcomes. How Does Rheumatoid Arthritis Affect Pregnancy Outcomes? Rheumatoid arthritis is an autoimmune condition where the body's immune system attacks joint tissues, causing inflammation and pain. When women with RA become pregnant, the disease can significantly impact both maternal health and fetal development. Active disease during pregnancy substantially increases the risk of nearly all adverse outcomes, making disease control before conception critically important. Research shows that women with RA experience a range of pregnancy complications at higher rates than the general population: - Miscarriage Risk: Women with RA have a miscarriage rate of approximately 19.8%, compared to just 0.9% in healthy women, representing a moderately increased risk that requires careful monitoring. - Preterm Birth: RA increases the odds of preterm delivery by 84%, meaning babies are born significantly earlier than the typical 40-week pregnancy. - Low Birth Weight: Babies born to mothers with RA are threefold more likely to have low birth weight, with odds ratios of 3.08, which can affect infant health and development. - Fetal Growth Restriction: RA increases the risk that babies do not grow at expected rates in the womb, with an 8% increased risk of fetal growth restriction. - Cesarean Delivery: Women with RA have cesarean section rates of 31.7%, compared to 14.6% in women without RA, nearly double the rate. - Hypertensive Disorders: RA is causally linked to gestational hypertension and preeclampsia, conditions that can threaten both mother and baby during pregnancy. Why Does Rheumatoid Arthritis Reduce Fertility? Women with RA often struggle to conceive or take longer to become pregnant than women without the condition. Up to 42% of women with RA who want to complete their families experience a time to pregnancy greater than 12 months, compared to the typical conception window for healthy women. Surveys reveal that more than 50% of women with RA have fewer pregnancies than they intended, with over 40% citing infertility as a contributing factor. Several factors contribute to reduced fertility in women with RA. Disease activity itself plays a significant role, as does the use of certain medications. Factors associated with longer times to pregnancy include age, having no previous pregnancies, and preconception use of nonsteroidal anti-inflammatory drugs (NSAIDs) and prednisone at doses exceeding 7.5 milligrams per day. These medications, while necessary to control RA symptoms, can interfere with conception. What Happens to Rheumatoid Arthritis During and After Pregnancy? Pregnancy creates a unique immunological environment that often benefits women with RA. About half of pregnant women with RA experience low disease activity, and 20% to 40% achieve complete remission by the third trimester. However, approximately 1 in 5 women continue to have moderate to high disease activity that requires ongoing treatment adjustments throughout pregnancy. The improvement in RA symptoms during pregnancy results from several overlapping physiologic changes. These include shifts in cellular immunity toward a pattern that suppresses inflammation, increases in anti-inflammatory substances like interleukin-1 receptor antagonist, and hormonal influences from elevated cortisol, estrogen, and progesterone levels. Additionally, changes in how the immune system produces antibodies and altered neutrophil activity contribute to symptom improvement. Unfortunately, the postpartum period brings a dramatic reversal. Published postpartum flare rates range from 39% to as high as 90%, with at least 39% of women experiencing at least one moderate disease flare within six months after delivery. This occurs because anti-inflammatory hormone levels decline, prolactin levels rise (a hormone with inflammatory effects), and the immune system reverts from its pregnancy-suppressed state back to its normal inflammatory pattern. How Should Women with RA Prepare for Pregnancy? Preconception planning is essential for women with RA who want to become pregnant. The goal is to achieve optimal suppression of disease activity while minimizing treatments that may adversely affect fertility or pregnancy outcomes. Women of reproductive age being treated for RA should receive comprehensive counseling before initiating or adjusting therapy, including detailed discussions about the teratogenic potential (ability to cause birth defects) and other pregnancy-related risks of disease-modifying antirheumatic drugs (DMARDs). Several commonly used RA medications require particular attention during preconception planning. Methotrexate, leflunomide, and cyclophosphamide are especially concerning because they can cause serious birth defects, necessitating strict contraception while using these agents. Because some DMARDs have prolonged half-lives, meaning they remain in the body for extended periods, they may need to be discontinued up to three months before attempting conception. In certain cases, accelerated drug elimination is required; for example, patients taking leflunomide may need a cholestyramine washout to ensure adequate clearance before trying to become pregnant. The American College of Rheumatology strongly advises that women with rheumatic diseases receive counseling on improved management strategies that balance disease control with pregnancy safety. Most women with RA can have successful pregnancies, especially when disease is well controlled before conception. Close co-management with both rheumatologists and maternal-fetal medicine specialists can significantly improve pregnancy outcomes and reduce the risk of complications. For women with RA considering pregnancy, the key takeaway is that while the condition does increase certain pregnancy risks, these risks are substantially reduced through careful preconception planning, medication optimization, and coordinated specialist care. Early consultation with both your rheumatologist and obstetrician is the critical first step in preparing for a healthy pregnancy.
